Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
These effects are usually temporary, often appear during dose increases, and tend to improve as the body adjusts
This indication diversification insulates GLP-1 manufacturers from reimbursement pressure in any single category while creating cross-indication pricing power
Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus
any deviation from the labeled dosing regimen should be decided upon in consultation with a clinician, as controlled trial evidence for microdosing is limited
US$ 26.00
US$ 28.85
US$ 24.50
